Events
The 25th annual BIO-Europe® global life sciences partnering event will be held November 11–13, 2019, in Hamburg, Germany, supported by regional hosts Life Science Nord, the City of Hamburg, and the State of Schleswig-Holstein.
Ergomed plc will announce its interim results for the six months ending 30 June 2019 on 25September 2019.
MyoKardia, Inc., announced its participation in the following upcoming investor conferences:
Catalyst Pharmaceuticals, Inc. announced that Patrick J. McEnany, Catalyst’s Chief Executive Officer and Steven Miller, Ph.D., Chief Scientific Officer/Chief Operating Officer will host one-on-one meetings with investors at the 14thAnnual Citi Biotech Conference on September 4th, 2019 at the Four Seasons Boston, Massachusetts.
TLC announced that the management team is scheduled to present at the two upcoming investor conferences
Colorado teenager Olivia Goodreau has garnered support from some of the world’s top scientists as a leading advocate for Lyme disease awareness and research funding.
Today the Society for Clinical Research Sites (SCRS) announced the top 5 sponsor and CRO finalists for the 2019 SCRS Eagle Award™, selected from companies nominated by SCRS members.
Eisai Co., Ltd. announced that it provides tanks to supply clean water for the neglected tropical diseases (NTDs) measuresto the endemic regions in Kenya in collaboration with Merck.
ASLAN Pharmaceuticals today announced that a late-breaking abstract detailing results from a phase 2 study of varlitinib in patients with advanced or metastatic biliary tract cancer in China has been accepted for oral presentation at the upcoming 2019 Chinese Society of Clinical Oncology (CSCO) in Xiamen, China on 19 September 2019.
MyoKardia, Inc. announced the presentation of three abstracts at the upcoming European Society of Cardiology Congress taking place August 31 – September 4, 2019 in Paris, France.
PRESS RELEASES